Psychemedics Corporation
PMD · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $13,203 | $13,615 | $13,670 | $16,315 |
| - Cash | $1,417 | $1,405 | $1,434 | $1,421 |
| + Debt | $1,166 | $1,579 | $1,868 | $1,960 |
| Enterprise Value | $12,952 | $13,789 | $14,104 | $16,854 |
| Revenue | $4,425 | $5,175 | $4,728 | $5,357 |
| % Growth | -14.5% | 9.5% | -11.7% | – |
| Gross Profit | $1,388 | $2,039 | $1,552 | $2,122 |
| % Margin | 31.4% | 39.4% | 32.8% | 39.6% |
| EBITDA | $584 | -$595 | -$235 | -$16 |
| % Margin | 13.2% | -11.5% | -5% | -0.3% |
| Net Income | $189 | -$535 | -$827 | -$688 |
| % Margin | 4.3% | -10.3% | -17.5% | -12.8% |
| EPS Diluted | 0.032 | -0.091 | -0.14 | -0.12 |
| % Growth | 135.2% | 35.1% | -16.7% | – |
| Operating Cash Flow | $1,019 | $263 | $120 | -$473 |
| Capital Expenditures | -$26 | $17 | -$39 | -$8 |
| Free Cash Flow | $993 | $280 | $81 | -$481 |